НовостиBenzingaHC Wainwright & Co. Maintains Buy on SpyGlass Pharma, Raises Price Target to $43 HC Wainwright & Co. Maintains Buy on SpyGlass Pharma, Raises Price Target to $43 Benzinga 2026.11.12 17:11 (GMT+0) Открыть на Benzinga Другие новости